Anticonvulsant drugs, particularly phenobarbital and phenytoin, are thought to affect calcium and vitamin D metabolism and to cause rickets or osteomalacia. The aim of this study was to elucidate the factors which lead to rachitic changes. For this purpose we measured serum concentrations of calcium, phosphorus, alkaline-phosphatase, 25-hydroxy-vitamin D (25-0H-D), and evaluated Σ GS/D (bone mineral content) using microdensi-tometry. The study was performed on 92 epileptic patients aged 3 to 22 years (mean 10.5) who had been receiving anticonvulsant drugs for 3 to 19 years (mean 5.8). According to the period of treatment, patients were divided into three groups: A, 3 to 4 years (43 cases); B, 5 to 9 years (34 cases); C, over 10 years (15 cases).
In 21 of the total 92 patients, particularly in 9 of the 15 patients of group C, serum calcium levels were lower than the lower limit of normal values obtained in age-matched controls. In 17 of the 92 patients, particularly in 8 of the 15 patients of group C, serum 25-OH-D levels were lower than the lower limit of normal value (14 ng/ml), and the values of ΣGS/D in 8 of the 17 patients were lower than the mean value-1.65 S. D. In 11 of the 80 patients, values of ΣGS/D were lower than the mean value-1.65 S. D., and almost all cases of the 11cases had been receiving multiple drugs concurrently for more than 7 years. In 8 of the 11, serum 25-OH-D levels were lower than the lower limit of the normal value.
It was concluded that long-term treatment with concurrent use to multiple drugs, was the factor leading to rachitic changes, and that evaluation of Σ GS/D together with serum calcium and 25-OH-D was useful for early detection of rachitic changes.
View full abstract